Series A Biotechnology Companies

Complete Omics is a developer of multi-omics diagnostics for early disease detection.

Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.

VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.

Cell fiber technology was developed as a basic technology for handling cells in the engineering field.

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment associated with schizophrenia (CIAS).

Healionics has developed a novel vascular graft, based on a platform biomaterial, offering improved vascular access for dialysis patients.

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.

Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics.

Pow.bio provides a genetically engineered solution for fermentation scientists.

MogrifyAE will transform the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.

Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

Automera focuses on a novel therapeutic methods to develop drugs.

traceless materials is a circular bioeconomy startup offering a holistically sustainable alternative to conventional plastics & bioplastics

TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.

Stane's objective is to mobilize collective wisdom to improve community medicine's performance.

Magnet Biomedicine is a biotechnology research platform specializing in discovering true molecular glues.